News
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...
Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
Delaware—the first of the 13 colonies to ratify the U.S. Constitution—also prides itself on being the state of incorporation for "more than 66% of the Fortune 500." The Delaware Supreme Court ...
A Delaware Superior Court judge will hear litigation Monday from plaintiffs who say their cancer was caused by Zantac. 24/7 Live Philadelphia Pennsylvania New Jersey Delaware Welcome, Mickey ...
Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
Shares of GSK plc (LON:GSK) rose on Wednesday after the Delaware Supreme Court granted the company’s request for an interlocutory review of the Delaware Superior Court's decision, which had ...
The Delaware Supreme Court unanimously sided with GSK , opens new tab, Pfizer , opens ... The case is In re Zantac (Ranitidine) Litigation, Delaware Supreme Court, No. 255, 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results